Shoulder Innovations (NYSE:SI) COO Matthew Fraser Ahearn Sells 15,856 Shares of Stock

Shoulder Innovations, Inc. (NYSE:SI) COO Matthew Fraser Ahearn sold 15,856 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $18.68, for a total transaction of $296,190.08. Following the sale, the chief operating officer directly owned 273,320 shares of the company’s stock, valued at approximately $5,105,617.60. This trade represents a 5.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Fraser Ahearn also recently made the following trade(s):

• On Monday, June 15th, Matthew Fraser Ahearn sold 4,144 shares of Shoulder Innovations stock. The stock was sold at an average price of $18.84, for a total transaction of $78,072.96.

Shoulder Innovations Stock Performance

Shares of SI stock opened at $18.78 on Wednesday. The company has a market cap of $389.40 million and a price-to-earnings ratio of -0.11. Shoulder Innovations, Inc. has a 52 week low of $10.92 and a 52 week high of $19.79. The company has a quick ratio of 10.04, a current ratio of 11.81 and a debt-to-equity ratio of 0.11. The firm has a 50 day moving average of $14.64 and a 200-day moving average of $14.40.

Shoulder Innovations (NYSE:SI) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.41) EPS for the quarter, topping the consensus estimate of ($0.44) by $0.03. The company had revenue of $16.71 million during the quarter. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. On average, equities analysts forecast that Shoulder Innovations, Inc. will post -1.67 earnings per share for the current year.

Institutional Trading of Shoulder Innovations

Several hedge funds have recently bought and sold shares of the business. TimesSquare Capital Management LLC bought a new position in Shoulder Innovations during the 3rd quarter valued at $4,799,000. Sectoral Asset Management Inc. lifted its stake in Shoulder Innovations by 14.4% during the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock valued at $7,042,000 after acquiring an additional 62,153 shares in the last quarter. Readystate Asset Management LP bought a new position in Shoulder Innovations during the 3rd quarter valued at $511,000. Monashee Investment Management LLC bought a new position in Shoulder Innovations during the 3rd quarter valued at $502,000. Finally, CM Management LLC bought a new position in Shoulder Innovations during the 4th quarter valued at $358,000.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Piper Sandler reissued an “overweight” rating and issued a $19.00 price target (up from $18.00) on shares of Shoulder Innovations in a research report on Friday, May 8th. BTIG Research lifted their price target on shares of Shoulder Innovations from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, March 11th. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $21.00.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.